Transdermal Drug Delivery Systems Market

Global Transdermal Drug Delivery Systems Market Size, Share & Industry Trends Analysis Report By Application (Analgesics, Hormone Replacement Therapies, Hypertension, Motion Sickness, Smoking Cessation), By Type of Delivery System, By Regional Outlook and Forecast, 2022 - 2028

Report Id: KBV-11636 Publication Date: September-2022 Number of Pages: 178
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Transdermal Drug Delivery Systems Market, by Application
1.4.2 Global Transdermal Drug Delivery Systems Market, by Type of Delivery System
1.4.3 Global Transdermal Drug Delivery Systems Market, by Geography
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Global Transdermal Drug Delivery Systems Market by Application
3.1 Global Analgesics Market by Region
3.2 Global Hormone Replacement Therapies Market by Region
3.3 Global Hypertension Market by Region
3.4 Global Motion Sickness Market by Region
3.5 Global Smoking Cessation Market by Region
3.6 Global Others Market by Region

Chapter 4. Global Transdermal Drug Delivery Systems Market by Type of Delivery System
4.1 Global Passive Market by Region
4.2 Global Active Market by Region

Chapter 5. Global Transdermal Drug Delivery Systems Market by Region
5.1 North America Transdermal Drug Delivery Systems Market
5.1.1 North America Transdermal Drug Delivery Systems Market by Application
5.1.1.1 North America Analgesics Market by Country
5.1.1.2 North America Hormone Replacement Therapies Market by Country
5.1.1.3 North America Hypertension Market by Country
5.1.1.4 North America Motion Sickness Market by Country
5.1.1.5 North America Smoking Cessation Market by Country
5.1.1.6 North America Others Market by Country
5.1.2 North America Transdermal Drug Delivery Systems Market by Type of Delivery System
5.1.2.1 North America Passive Market by Country
5.1.2.2 North America Active Market by Country
5.1.3 North America Transdermal Drug Delivery Systems Market by Country
5.1.3.1 US Transdermal Drug Delivery Systems Market
5.1.3.1.1 US Transdermal Drug Delivery Systems Market by Application
5.1.3.1.2 US Transdermal Drug Delivery Systems Market by Type of Delivery System
5.1.3.2 Canada Transdermal Drug Delivery Systems Market
5.1.3.2.1 Canada Transdermal Drug Delivery Systems Market by Application
5.1.3.2.2 Canada Transdermal Drug Delivery Systems Market by Type of Delivery System
5.1.3.3 Mexico Transdermal Drug Delivery Systems Market
5.1.3.3.1 Mexico Transdermal Drug Delivery Systems Market by Application
5.1.3.3.2 Mexico Transdermal Drug Delivery Systems Market by Type of Delivery System
5.1.3.4 Rest of North America Transdermal Drug Delivery Systems Market
5.1.3.4.1 Rest of North America Transdermal Drug Delivery Systems Market by Application
5.1.3.4.2 Rest of North America Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2 Europe Transdermal Drug Delivery Systems Market
5.2.1 Europe Transdermal Drug Delivery Systems Market by Application
5.2.1.1 Europe Analgesics Market by Country
5.2.1.2 Europe Hormone Replacement Therapies Market by Country
5.2.1.3 Europe Hypertension Market by Country
5.2.1.4 Europe Motion Sickness Market by Country
5.2.1.5 Europe Smoking Cessation Market by Country
5.2.1.6 Europe Others Market by Country
5.2.2 Europe Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.2.1 Europe Passive Market by Country
5.2.2.2 Europe Active Market by Country
5.2.3 Europe Transdermal Drug Delivery Systems Market by Country
5.2.3.1 Germany Transdermal Drug Delivery Systems Market
5.2.3.1.1 Germany Transdermal Drug Delivery Systems Market by Application
5.2.3.1.2 Germany Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.2 UK Transdermal Drug Delivery Systems Market
5.2.3.2.1 UK Transdermal Drug Delivery Systems Market by Application
5.2.3.2.2 UK Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.3 France Transdermal Drug Delivery Systems Market
5.2.3.3.1 France Transdermal Drug Delivery Systems Market by Application
5.2.3.3.2 France Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.4 Russia Transdermal Drug Delivery Systems Market
5.2.3.4.1 Russia Transdermal Drug Delivery Systems Market by Application
5.2.3.4.2 Russia Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.5 Spain Transdermal Drug Delivery Systems Market
5.2.3.5.1 Spain Transdermal Drug Delivery Systems Market by Application
5.2.3.5.2 Spain Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.6 Italy Transdermal Drug Delivery Systems Market
5.2.3.6.1 Italy Transdermal Drug Delivery Systems Market by Application
5.2.3.6.2 Italy Transdermal Drug Delivery Systems Market by Type of Delivery System
5.2.3.7 Rest of Europe Transdermal Drug Delivery Systems Market
5.2.3.7.1 Rest of Europe Transdermal Drug Delivery Systems Market by Application
5.2.3.7.2 Rest of Europe Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3 Asia Pacific Transdermal Drug Delivery Systems Market
5.3.1 Asia Pacific Transdermal Drug Delivery Systems Market by Application
5.3.1.1 Asia Pacific Analgesics Market by Country
5.3.1.2 Asia Pacific Hormone Replacement Therapies Market by Country
5.3.1.3 Asia Pacific Hypertension Market by Country
5.3.1.4 Asia Pacific Motion Sickness Market by Country
5.3.1.5 Asia Pacific Smoking Cessation Market by Country
5.3.1.6 Asia Pacific Others Market by Country
5.3.2 Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.2.1 Asia Pacific Passive Market by Country
5.3.2.2 Asia Pacific Active Market by Country
5.3.3 Asia Pacific Transdermal Drug Delivery Systems Market by Country
5.3.3.1 China Transdermal Drug Delivery Systems Market
5.3.3.1.1 China Transdermal Drug Delivery Systems Market by Application
5.3.3.1.2 China Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.2 Japan Transdermal Drug Delivery Systems Market
5.3.3.2.1 Japan Transdermal Drug Delivery Systems Market by Application
5.3.3.2.2 Japan Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.3 India Transdermal Drug Delivery Systems Market
5.3.3.3.1 India Transdermal Drug Delivery Systems Market by Application
5.3.3.3.2 India Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.4 South Korea Transdermal Drug Delivery Systems Market
5.3.3.4.1 South Korea Transdermal Drug Delivery Systems Market by Application
5.3.3.4.2 South Korea Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.5 Singapore Transdermal Drug Delivery Systems Market
5.3.3.5.1 Singapore Transdermal Drug Delivery Systems Market by Application
5.3.3.5.2 Singapore Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.6 Malaysia Transdermal Drug Delivery Systems Market
5.3.3.6.1 Malaysia Transdermal Drug Delivery Systems Market by Application
5.3.3.6.2 Malaysia Transdermal Drug Delivery Systems Market by Type of Delivery System
5.3.3.7 Rest of Asia Pacific Transdermal Drug Delivery Systems Market
5.3.3.7.1 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Application
5.3.3.7.2 Rest of Asia Pacific Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4 LAMEA Transdermal Drug Delivery Systems Market
5.4.1 LAMEA Transdermal Drug Delivery Systems Market by Application
5.4.1.1 LAMEA Analgesics Market by Country
5.4.1.2 LAMEA Hormone Replacement Therapies Market by Country
5.4.1.3 LAMEA Hypertension Market by Country
5.4.1.4 LAMEA Motion Sickness Market by Country
5.4.1.5 LAMEA Smoking Cessation Market by Country
5.4.1.6 LAMEA Others Market by Country
5.4.2 LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.2.1 LAMEA Passive Market by Country
5.4.2.2 LAMEA Active Market by Country
5.4.3 LAMEA Transdermal Drug Delivery Systems Market by Country
5.4.3.1 Brazil Transdermal Drug Delivery Systems Market
5.4.3.1.1 Brazil Transdermal Drug Delivery Systems Market by Application
5.4.3.1.2 Brazil Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.2 Argentina Transdermal Drug Delivery Systems Market
5.4.3.2.1 Argentina Transdermal Drug Delivery Systems Market by Application
5.4.3.2.2 Argentina Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.3 UAE Transdermal Drug Delivery Systems Market
5.4.3.3.1 UAE Transdermal Drug Delivery Systems Market by Application
5.4.3.3.2 UAE Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.4 Saudi Arabia Transdermal Drug Delivery Systems Market
5.4.3.4.1 Saudi Arabia Transdermal Drug Delivery Systems Market by Application
5.4.3.4.2 Saudi Arabia Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.5 South Africa Transdermal Drug Delivery Systems Market
5.4.3.5.1 South Africa Transdermal Drug Delivery Systems Market by Application
5.4.3.5.2 South Africa Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.6 Nigeria Transdermal Drug Delivery Systems Market
5.4.3.6.1 Nigeria Transdermal Drug Delivery Systems Market by Application
5.4.3.6.2 Nigeria Transdermal Drug Delivery Systems Market by Type of Delivery System
5.4.3.7 Rest of LAMEA Transdermal Drug Delivery Systems Market
5.4.3.7.1 Rest of LAMEA Transdermal Drug Delivery Systems Market by Application
5.4.3.7.2 Rest of LAMEA Transdermal Drug Delivery Systems Market by Type of Delivery System

Chapter 6. Company Profiles
6.1 Viatris, Inc.
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Approval:
6.2 Purdue Pharma L.P.
6.2.1 Company Overview
6.3 Bayer AG
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Novartis AG
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Boehringer Ingelheim International Gmbh
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional & Segmental Analysis
6.5.4 Research & Development Expenses
6.6 GlaxoSmithKline PLC
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Johnson & Johnson
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental &Regional Analysis
6.7.4 Research & Development Expenses
6.8 Endo International PLC
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 Altaris Capital Partners, LLC
6.9.1 Company Overview
6.9.2 Recent strategies and developments:
6.9.2.1 Acquisition and Mergers:
6.10. Hisamitsu Pharmaceutical Co. Inc.
6.10.1 Company Overview
6.10.2 Financial Analysis
6.10.3 Recent strategies and developments:
6.10.3.1 Approval:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo